Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.81 | -$0.77 | -$0.79 |
| Q2 2026 | 4 | -$0.61 | -$0.48 | -$0.55 |
| Q3 2026 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2026 | 2 | -$0.63 | -$0.63 | -$0.63 |
| Q1 2027 | 2 | -$0.37 | -$0.37 | -$0.37 |
| Q2 2027 | 1 | -$0.37 | -$0.37 | -$0.37 |
| Q3 2027 | 1 | -$0.39 | -$0.39 | -$0.39 |
| Q4 2027 | 2 | -$0.41 | -$0.41 | -$0.41 |
| Q1 2028 | 3 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2028 | 2 | -$0.08 | -$0.08 | -$0.08 |
| Q3 2028 | 2 | -$0.09 | -$0.09 | -$0.09 |
| Q4 2028 | 3 | -$0.10 | -$0.10 | -$0.10 |
CervoMed Inc last posted its earnings results on Friday, March 13th, 2026. The company reported $-0.88 earnings per share for the quarter, missing analysts' consensus estimates of $-0.79 by $0.09. The company had revenue of 0 for the quarter and had revenue of 4.01 M for the year. CervoMed Inc has generated $-3 earnings per share over the last year ($-2.98 diluted earnings per share) and currently has a price-to-earnings ratio of -1.29. CervoMed Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/13/2026 | Q4 2025 | -$0.79 | -$0.87 | -0.08 | $90.84 K | $0 |
| 11/07/2025 | Q3 2025 | -$0.68 | -$0.84 | -0.16 | $1.21 M | $322.57 K |
| 08/08/2025 | Q2 2025 | -$0.57 | -$0.70 | -0.13 | $1.39 M | $0 |
| 05/12/2025 | Q1 2025 | -$0.60 | -$0.56 | 0.04 | $1.72 M | $0 |
| 03/17/2025 | Q4 2024 | -$0.67 | -$0.77 | -0.1 | $1.53 M | $0 |
| 11/12/2024 | Q3 2024 | -$0.41 | -$0.55 | -0.14 | $2.30 M | $0 |
| 08/09/2024 | Q2 2024 | -$0.24 | -$0.27 | -0.03 | $1.58 M | $0 |
| 05/14/2024 | Q1 2024 | -$0.46 | -$0.41 | 0.05 | $2.35 M | $0 |
| 03/29/2024 | Q4 2023 | N/A | -$0.42 | N/A | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | $0.65 | N/A | N/A | $0 |
| 06/29/2023 | Q2 2023 | N/A | -$1.55 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$3.01 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$3.00 | N/A | N/A | $0 |
| 09/28/2022 | Q3 2022 | N/A | -$1.70 | N/A | N/A | $0 |
| 06/28/2022 | Q2 2022 | N/A | -$3.08 | N/A | N/A | $0 |
| 03/29/2022 | Q1 2022 | N/A | -$3.33 | N/A | N/A | $0 |
| 12/29/2021 | Q4 2021 | N/A | -$2.56 | N/A | N/A | $0 |
| 09/28/2021 | Q3 2021 | N/A | -$8.98 | N/A | N/A | $0 |
| 06/30/2021 | Q2 2021 | N/A | -$2.78 | N/A | N/A | $0 |
| 03/31/2021 | Q1 2021 | N/A | -$4.21 | N/A | N/A | $0 |
The conference call for CervoMed Inc's latest earnings report can be listened to online.
The conference call transcript for CervoMed Inc's latest earnings report can be read online.
CervoMed Inc (:CRVO) has a recorded annual revenue of $4.01 M.
CervoMed Inc (:CRVO) has a recorded net income of $-26,966,367.CervoMed Inc has generated $-2.98 earnings per share over the last four quarters.
CervoMed Inc (:CRVO) has a price-to-earnings ratio of -1.29 and price/earnings-to-growth ratio is 0.04.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED